Try our Advanced Search for more refined results

Biotech Firm NantHealth's CEO Can't Escape Stockholder Suit

By Reenat Sinay ( January 14, 2020, 10:34 PM EST) -- The billionaire founder and CEO of biotech startup NantHealth Inc. was left as the lone defendant in a shareholder derivative suit over a research deal in Delaware Chancery Court on Tuesday after the chancellor dismissed the six other directors and former officers due to lack of evidence....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!